Urmăriți
Yoann Aldon
Yoann Aldon
PhD
Adresă de e-mail confirmată pe amsterdamumc.nl
Titlu
Citat de
Citat de
Anul
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
PJM Brouwer, TG Caniels, K van der Straten, JL Snitselaar, Y Aldon, ...
Science 369 (6504), 643-650, 2020
12602020
Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study
KM Hastie, H Li, D Bedinger, SL Schendel, SM Dennison, K Li, ...
Science 374 (6566), 472-478, 2021
3102021
The effect of spike mutations on SARS-CoV-2 neutralization
C Rees-Spear, L Muir, SA Griffith, J Heaney, Y Aldon, JL Snitselaar, ...
Cell reports 34 (12), 2021
2652021
The effect of spike mutations on SARS-CoV-2 neutralization
C Rees-Spear, L Muir, SA Griffith, J Heaney, Y Aldon, JL Snitselaar, ...
Cell reports 34 (12), 2021
2652021
Inside out: optimization of lipid nanoparticle formulations for exterior complexation and in vivo delivery of saRNA
AK Blakney, PF McKay, BI Yus, Y Aldon, RJ Shattock
Gene therapy 26 (9), 363-372, 2019
2012019
Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection
PJM Brouwer, M Brinkkemper, P Maisonnasse, N Dereuddre-Bosquet, ...
Cell 184 (5), 1188-1200. e19, 2021
1762021
Rational design of DNA-expressed stabilized native-like HIV-1 envelope trimers
Y Aldon, PF McKay, J Allen, G Ozorowski, RF Lévai, M Tolazzi, P Rogers, ...
Cell reports 24 (12), 3324-3338. e5, 2018
612018
COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models
P Maisonnasse, Y Aldon, A Marc, R Marlin, N Dereuddre-Bosquet, ...
Nature communications 12 (1), 1-10, 2021
522021
A public antibody class recognizes an S2 epitope exposed on open conformations of SARS-CoV-2 spike
M Claireaux, TG Caniels, M de Gast, J Han, D Guerra, G Kerster, ...
Nature Communications 13 (1), 4539, 2022
512022
Effects of cationic adjuvant formulation particle type, fluidity and immunomodulators on delivery and immunogenicity of saRNA
AK Blakney, PF McKay, D Christensen, BI Yus, Y Aldon, F Follmann, ...
Journal of Controlled Release 304, 65-74, 2019
512019
Enhancing glycan occupancy of soluble HIV-1 envelope trimers to mimic the native viral spike
R Derking, JD Allen, CA Cottrell, K Sliepen, GE Seabright, WH Lee, ...
Cell Reports 35 (1), 108933, 2021
492021
Identification of potential biomarkers of vaccine inflammation in mice
PF McKay, D Cizmeci, Y Aldon, J Maertzdorf, J Weiner, SHE Kaufmann, ...
Elife 8, e46149, 2019
412019
Probing Affinity, Avidity, Anticooperativity, and Competition in Antibody and Receptor Binding to the SARS-CoV-2 Spike by Single Particle Mass Analyses
V Yin, SH Lai, TG Caniels, PJM Brouwer, M Brinkkemper, Y Aldon, H Liu, ...
ACS central science 7 (11), 1863-1873, 2021
282021
Intravaginal immunisation using a novel antigen-releasing ring device elicits robust vaccine antigen-specific systemic and mucosal humoral immune responses
PF McKay, JFS Mann, A Pattani, V Kett, Y Aldon, D King, RK Malcolm, ...
Journal of Controlled Release 249, 74-83, 2017
282017
Germline-targeting HIV-1 Env vaccination induces VRC01-class antibodies with rare insertions
TG Caniels, M Medina-Ramírez, J Zhang, A Sarkar, S Kumar, ...
Cell Reports Medicine 4 (4), 2023
272023
Immunogenicity of stabilized HIV-1 Env trimers delivered by self-amplifying mRNA
Y Aldon, PF McKay, JM Herrero, AB Vogel, R Lévai, P Maisonnasse, ...
Molecular Therapy-Nucleic Acids 25, 483-493, 2021
232021
A phase 1 human immunodeficiency virus vaccine trial for cross-profiling the kinetics of serum and mucosal antibody responses to CN54gp140 modulated by two homologous prime …
S Kratochvil, PF McKay, JT Kopycinski, C Bishop, PJ Hayes, L Muir, ...
Frontiers in immunology 8, 595, 2017
192017
Discrete partitioning of HIV-1 Env forms revealed by viral capture
DJ Stieh, DF King, K Klein, Y Aldon, PF McKay, RJ Shattock
Retrovirology 12, 1-15, 2015
182015
Chemokine-Adjuvanted Plasmid DNA Induces Homing of Antigen-Specific and Non–Antigen-Specific B and T Cells to the Intestinal and Genital Mucosae
Y Aldon, S Kratochvil, RJ Shattock, PF McKay
The Journal of Immunology 204 (4), 903-913, 2020
122020
Next-generation bNAbs for HIV-1 cure strategies
AI Schriek, YLT Aldon, MJ van Gils, SW de Taeye
Antiviral research 222, 105788, 2024
112024
Sistemul nu poate realiza operația în acest moment. Încercați din nou mai târziu.
Articole 1–20